BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 8448558)

  • 1. Allogeneic family-unrelated bone marrow transplantation in acute and chronic myeloid leukemia.
    Fauser AA; Köchling G; Digel W; Finke J; Thiel M; Heinz J; Bross KJ; Dölken G; Mertelsmann R
    Bone Marrow Transplant; 1993; 11 Suppl 1():83. PubMed ID: 8448558
    [No Abstract]   [Full Text] [Related]  

  • 2. Frequency and indication of unrelated bone marrow transplants in Europe. European Group of Bone Marrow Transplantation (EBMT).
    Gratwohl A; Hermans J
    Bone Marrow Transplant; 1993; 11 Suppl 1():62-5. PubMed ID: 8448551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial experiences in allogeneic bone marrow transplantation for leukaemias: report of National Institute of Haematology and Blood Transfusion (Hungary).
    Poros A; Petrányi J; Harsányi V; Mód A; Bernyäk J; Hollán Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):409-11. PubMed ID: 2480282
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone marrow transplantation for leukemia after conditioning with busulfan and cyclophosphamide. Bone marrow morphology in the early recovery phase.
    Cao DC; Tutschka PJ
    Chin Med J (Engl); 1991 Apr; 104(4):267-76. PubMed ID: 2065543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New therapeutic possibilities for leukemia in adults. Indications and progress measures for allogeneic bone marrow transplantation].
    Brinch L; Evensen SA; Albrechtsen D; Egeland T
    Tidsskr Nor Laegeforen; 1991 Jan; 111(3):316-9. PubMed ID: 2000611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of childhood leukemias.
    Pui CH; Crist WM
    Curr Opin Oncol; 1995 Jan; 7(1):36-44. PubMed ID: 7696362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of acute and chronic leukemias].
    Mandelli F; Montefusco E
    Recenti Prog Med; 1999 Nov; 90(11):605-12. PubMed ID: 10608151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency of polyomavirus infection in lymphoid cell preparations after allogeneic bone marrow transplantation.
    Schneider EM; Dörries K
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1271-3. PubMed ID: 8382856
    [No Abstract]   [Full Text] [Related]  

  • 9. [The role of bone marrow transplantation in the treatment of leukemia].
    Robak T
    Przegl Lek; 1990; 47(10):723-7. PubMed ID: 2089452
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic myeloid leukemia treated by allogeneic bone marrow transplantation.
    Szer J; Sheridan WP
    Transplant Proc; 1992 Feb; 24(1):181-2. PubMed ID: 1539235
    [No Abstract]   [Full Text] [Related]  

  • 11. Importance of bone marrow cell dose in bone marrow transplantation.
    Paulin T
    Clin Transplant; 1992 Feb; 6(1):48-54. PubMed ID: 10150090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic bone marrow transplantation from HLA-identical siblings following conditioning with busulfan and cyclophosphamide. First results.
    Wiktor-Jedrzejczak W; Szczylik C; Matej H; Pojda Z; Ratajczak MZ; Myc A; Siekierzyński M; Kansy J; Kłos M; Rybicki Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):403-8. PubMed ID: 2480281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow transplantation. The state of the art.
    Thomas ED
    Ann Ital Med Int; 1986 Jun; 1(2):109-14. PubMed ID: 3079358
    [No Abstract]   [Full Text] [Related]  

  • 14. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
    Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
    Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal microvascular changes following bone marrow transplantation: the role of cyclosporine.
    O'Riordan JM; FitzSimon S; O'Connor M; McCann SR
    Bone Marrow Transplant; 1994 Jan; 13(1):101-4. PubMed ID: 8019445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged administration of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) after T-cell-depleted allogeneic bone marrow transplantation.
    De Witte T; Vreugdenhil G; Schattenberg A
    Transplant Proc; 1993 Aug; 25(4 Suppl 3):57-60. PubMed ID: 8351721
    [No Abstract]   [Full Text] [Related]  

  • 17. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
    Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Italian study comparing allogeneic and autologous BMT in childhood acute lymphoblastic leukemia using HD-vincristine, F-TBI and cyclophosphamide.
    Uderzo C; Colleselli P; Dini G; Bonetti F; Andolina F; Bagnulo S; Miniero R; Rondelli R; Balduzzi A; Locasciulli A
    Bone Marrow Transplant; 1991; 7 Suppl 3():19-21. PubMed ID: 1855081
    [No Abstract]   [Full Text] [Related]  

  • 19. Controversies on the role of bone marrow transplantation for patients with hematopoietic malignancies.
    Geller RB
    Mt Sinai J Med; 1994 Jan; 61(1):13-22. PubMed ID: 8183287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow transplantation for chronic myeloid leukaemia.
    Goldman JM
    Bone Marrow Transplant; 1991; 7 Suppl 2():62-3. PubMed ID: 1878724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.